Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin for prevention of postoperative urinary retention after TAPP inguinal hernia repair
ChiCTR2100045142Phase 4Recruiting
- Sponsor
- The First Hospital of Lanzhou University
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative urinary retention (POUR) comparing Tamsulosin intervention group with Placebo control group (2 arms). Started May 2021; status: recruiting.
02
Drugs
tamsulosin
03
Conditions
postoperative urinary retention (POUR)
Beyond the preview
Go deeper on ChiCTR2100045142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045142.